Repligen. and CRC shall not disparage each other or each other’s products, whether in public or private. Any factual statements contained in labeling approved by FDA or advertising submitted to FDA shall be expressly permitted and shall not constitute disparagement. Any such labeling or advertising shall be provided to either Party upon request of the other Party.
Appears in 2 contracts
Sources: Settlement Agreement, Settlement Agreement (Repligen Corp)